Evaluating the Safety and Efficacy of the Maurora® DES in ICAS

NACompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

May 15, 2025

Conditions
Intracranial ArteriosclerosisStroke (CVA) or TIA
Interventions
DEVICE

Maurora® Sirolimus Eluting Stent System

The Maurora® for intracranial PTA treatment comprises of a balloon expandable sirolimus eluting stent and a delivery catheter that features a rapid exchange catheter design with a semi-compliant balloon located at its distal end.

DEVICE

APOLLO™ Intracranial Stent System

The Apollo stent system comprises of a balloon expandable stent and a delivery catheter that features a rapid exchange catheter design with a semi-compliant balloon located at its distal end.

Trial Locations (1)

100070

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
collaborator

Alain Medical (Beijing) Co., Ltd.

UNKNOWN

lead

Beijing Tiantan Hospital

OTHER